Cargando…

Autoantibodies to BRAF, a new family of autoantibodies associated with rheumatoid arthritis

INTRODUCTION: BRAF (v raf murine sarcoma viral oncogene homologue B1) is a serine-threonine kinase involved in the mitogen-activated protein kinase (MAPK) signalling pathway, known to be implicated in the production of pro-inflammatory cytokines. We have observed that sera from rheumatoid arthritis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Charpin, Caroline, Martin, Marielle, Balandraud, Nathalie, Roudier, Jean, Auger, Isabelle
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2991030/ https://www.ncbi.nlm.nih.gov/pubmed/20955560 http://dx.doi.org/10.1186/ar3165

Ejemplares similares

New autoantibodies in early rheumatoid arthritis
por: Charpin, Caroline, et al.
Publicado: (2013)

How microchimerism can impart HLA susceptibility in patients with rheumatoid arthritis
por: Azzouz, Doua F., et al.
Publicado: (2010)

HLA-DRB1 Genotypes and the Risk of Developing Anti Citrullinated Protein Antibody (ACPA) Positive Rheumatoid Arthritis
por: Balandraud, Nathalie, et al.
Publicado: (2013)

In Rheumatoid Arthritis Patients, HLA-DRB1*04:01 and Rheumatoid Nodules Are Associated With ACPA to a Particular Fibrin Epitope
por: Larid, Guillaume, et al.
Publicado: (2021)

Influence of HLA-DR genes on the production of rheumatoid arthritis-specific autoantibodies to citrullinated fibrin
por: Auger, I, et al.
Publicado: (2005)

Long term treatment with abatacept or tocilizumab does not increase Epstein-Barr virus load in patients with rheumatoid arthritis - A three years retrospective study
por: Balandraud, Nathalie, et al.
Publicado: (2017)

Autoantibodies against the Catalytic Domain of BRAF Are Not Specific Serum Markers for Rheumatoid Arthritis
por: Li, Wenli, et al.
Publicado: (2011)

Peptidylarginine Deiminase Autoimmunity and the Development of Anti–Citrullinated Protein Antibody in Rheumatoid Arthritis: The Hapten–Carrier Model
por: Auger, Isabelle, et al.
Publicado: (2020)

How RA Associated HLA-DR Molecules Contribute to the Development of Antibodies to Citrullinated Proteins: The Hapten Carrier Model
por: Roudier, Jean, et al.
Publicado: (2022)

Evaluation of X Chromosome Inactivation with Respect to HLA Genetic Susceptibility in Rheumatoid Arthritis and Systemic Sclerosis
por: Kanaan, Sami B., et al.
Publicado: (2016)

Autoantibodies in rheumatoid arthritis and their clinical significance
por: Steiner, Günter, et al.
Publicado: (2002)

Autoantibodies to Posttranslational Modifications in Rheumatoid Arthritis
por: Burska, Agata N., et al.
Publicado: (2014)

The Clinical Value of Autoantibodies in Rheumatoid Arthritis
por: Bugatti, Serena, et al.
Publicado: (2018)

The role of autoantibodies in the pathophysiology of rheumatoid arthritis
por: Derksen, V. F. A. M., et al.
Publicado: (2017)

Therapeutic implications of autoantibodies in rheumatoid arthritis
por: Aletaha, Daniel, et al.
Publicado: (2016)

Natural autoantibodies reactive with glycosaminoglycans in rheumatoid arthritis
por: György, Bence, et al.
Publicado: (2008)

Autoantibodies in normals – the value of predicting rheumatoid arthritis
por: Dörner, Thomas, et al.
Publicado: (2004)

The Spectrum and Clinical Significance of Autoantibodies in Rheumatoid Arthritis
por: Castelar-Pinheiro, Geraldo da Rocha, et al.
Publicado: (2015)

Autoantibodies in Rheumatoid Arthritis – Laboratory and Clinical Perspectives
por: Rönnelid, Johan, et al.
Publicado: (2021)

Functional Analysis of Autoantibody Signatures in Rheumatoid Arthritis
por: Milchram, Lisa, et al.
Publicado: (2022)

TWEAK-binding autoantibodies are generated during psoriatic arthritis and are not influenced by anti-TNF therapy
por: Guis, Sandrine, et al.
Publicado: (2016)

Antinuclear Antibodies in Patients with Psoriatic Arthritis Treated or Not with Biologics
por: Silvy, Florent, et al.
Publicado: (2015)

Leveraging whole blood based functional flow cytometry assays to open new perspectives for rheumatoid arthritis translational research
por: Cartagena García, Celia, et al.
Publicado: (2022)

Epstein–Barr virus load follow up in rheumatoid arthritis patients treated with TNF-α inhibitors
por: Balandraud, N, et al.
Publicado: (2004)

Epstein–Barr virus load is higher in rheumatoid arthritis patients than in normal controls
por: Pieri-Balandraud, N, et al.
Publicado: (2003)

Autoantibodies in rheumatoid arthritis: rheumatoid factors and anticitrullinated protein antibodies
por: Song, Y.W., et al.
Publicado: (2010)

Anti-Ephrin Type-B Receptor 2 (EphB2) and Anti-Three Prime Histone mRNA EXonuclease 1 (THEX1) Autoantibodies in Scleroderma and Lupus
por: Azzouz, Doua F., et al.
Publicado: (2016)

Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset
por: Goldbach-Mansky, Raphaela, et al.
Publicado: (2000)

Influence of methotrexate, leflunomide and tumour necrosis factor alpha inhibitors on immune competence in rheumatoid arthritis patients: a long-run monitoring of Epstein–Barr virus load
por: Balandraud, N, et al.
Publicado: (2005)

Mosaicism of XX and XXY cells accounts for high copy number of Toll like Receptor 7 and8 genes in peripheral blood of men with Rheumatoid Arthritis
por: Martin, Gabriel V., et al.
Publicado: (2019)

Autoantibodies and B Cells: The ABC of rheumatoid arthritis pathophysiology
por: Volkov, Mikhail, et al.
Publicado: (2019)

Autoantibodies in Rheumatoid Arthritis: Historical Background and Novel Findings
por: Sokolova, Maria V., et al.
Publicado: (2021)

Autoantibodies against complement factor B in rheumatoid arthritis
por: Matola, Alexandra T., et al.
Publicado: (2023)

Serum Autoantibody Biomarkers for Management of Rheumatoid Arthritis Disease
por: Sánchez-Tirado, Esther, et al.
Publicado: (2023)

When Autoantibodies Are Missing: The Challenge of Seronegative Rheumatoid Arthritis
por: Paroli, Marino, et al.
Publicado: (2023)

Comparing cost-utility of DMARDs in autoantibody-negative rheumatoid arthritis patients
por: Nathalie, Luurssen-Masurel, et al.
Publicado: (2021)

Association Between Bone Mineral Density and Autoantibodies in Patients With Rheumatoid Arthritis
por: Amkreutz, Josephine A. M. P., et al.
Publicado: (2021)

The association between autoantibodies and risk for venous thromboembolic events among patients with rheumatoid arthritis
por: Westerlind, Helga, et al.
Publicado: (2022)

Patients with ACPA-positive and ACPA-negative rheumatoid arthritis show different serological autoantibody repertoires and autoantibody associations with disease activity
por: Cunningham, Kevin Y., et al.
Publicado: (2023)

The diagnostic significance of autoantibodies in patients with very early rheumatoid arthritis
por: Nell, V, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_pssbjhaevf1lhgqg4lvcta15gt